LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 171 filers reported holding LEGEND BIOTECH CORP in Q4 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $204 | -95.0% | 3,385 | -94.4% | 0.00% | -93.3% |
| Q3 2023 | $4,091 | -89.5% | 60,911 | -89.2% | 0.02% | -88.8% |
| Q2 2023 | $38,913 | +1330.1% | 563,709 | +899.0% | 0.13% | +1240.0% |
| Q1 2023 | $2,721 | -86.3% | 56,428 | -85.8% | 0.01% | -85.9% |
| Q4 2022 | $19,856 | -99.9% | 397,756 | +3.0% | 0.07% | +22.4% |
| Q3 2022 | $15,757,000 | -62.2% | 386,194 | -49.1% | 0.06% | -60.5% |
| Q2 2022 | $41,700,000 | – | 758,179 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FengHe Fund Management Pte. Ltd. | 372,989 | $10,824,000 | 8.53% |
| Johnson & Johnson Innovation - JJDC, Inc. | 1,629,173 | $47,279,000 | 6.12% |
| Vivo Capital, LLC | 2,755,007 | $79,950,000 | 2.81% |
| Consonance Capital Management LP | 896,608 | $26,020,000 | 2.77% |
| Yong Rong (HK) Asset Management Ltd | 198,312 | $5,756,000 | 1.58% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,054,242 | $30,594,000 | 1.28% |
| Hudson Bay Capital Management LP | 2,167,274 | $62,894,000 | 0.78% |
| Capital International, Inc./CA/ | 1,916,845 | $55,627,000 | 0.52% |
| Capital International Sarl | 172,546 | $5,007,000 | 0.48% |
| Novo Holdings A/S | 254,176 | $7,376,000 | 0.30% |